⚡ This is your brand? Claim your page free and bring it to life on AI search.
HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg)
About HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg)
Discover HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg), a prescription medicine used to treat adults with chronic Hep C. See Important Safety Information, including Important Warning.
Key Topics
Details
Category: Healthcare
harvoni.comAI Visibility Breakdown
1
Structured Data
6
Content Structure
6
Entity Clarity
4
E-E-A-T Signals
6
Technical AEO
2
AI Discoverability
Is this your brand?
Claim your free page to manage and improve your AI visibility score.
Trust Is the Product. AI Is How You Build It at Scale.
In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg).
Source & Attribution
Scored by Engagemii on June 1, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/harvoni
Cite this score: Engagemii (2026). "AEO Score for HARVONI® (ledipasvir 90 mg/sofosbuvir 400 mg)." Retrieved from https://engagemii.com/aeo/brands/harvoni
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform